Cargando…
The Elevated Serum Level of IFN-γ in Patients with Failed Back Surgery Syndrome Remains Unchanged after Spinal Cord Stimulation
OBJECTIVES: We investigated the influence of spinal cord stimulation (SCS) on IFN-γ, IL-1β, IL-6, TNF-α, IL-10, and TGF-β serum levels in failed back surgery syndrome (FBSS) patients. The study will try to give new insights into the mechanism of SCS action and the role of IFN-γ and other cytokines i...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6348905/ https://www.ncbi.nlm.nih.gov/pubmed/30755780 http://dx.doi.org/10.1155/2019/2606808 |
_version_ | 1783390187695374336 |
---|---|
author | Kamieniak, Piotr Bielewicz, Joanna Grochowski, Cezary Litak, Jakub Bojarska-Junak, Agnieszka Daniluk, Beata Trojanowski, Tomasz |
author_facet | Kamieniak, Piotr Bielewicz, Joanna Grochowski, Cezary Litak, Jakub Bojarska-Junak, Agnieszka Daniluk, Beata Trojanowski, Tomasz |
author_sort | Kamieniak, Piotr |
collection | PubMed |
description | OBJECTIVES: We investigated the influence of spinal cord stimulation (SCS) on IFN-γ, IL-1β, IL-6, TNF-α, IL-10, and TGF-β serum levels in failed back surgery syndrome (FBSS) patients. The study will try to give new insights into the mechanism of SCS action and the role of IFN-γ and other cytokines in neuropathic pain (NP) development. MATERIALS AND METHODS: Clinical and biochemical assessment was conducted in four groups of patients: group 0 consisted of 24 FBSS patients qualified to SCS therapy, group 1 included 17 patients who were one month after implantation, group 2 featured 12 patients who were 3 months after the implantation, and group C (the control group) with no NP. Clinical status was assessed with the use of Numeric Rating Scale (NRS), the Pain Rating Index of McGill Pain Questionnaire (SF-MPQ), the Oswestry Disability Index (ODI), and Beck Depression Inventory (BDI). The plasma concentrations of IFN-γ were ascertained by an immunoenzymatic method. RESULTS: We found a significant difference between the patients before SCS and controls' serum level of IFN-γ. Similarly, a significantly higher level of TNF-α and significantly lower level of IL-10 in FBSS patients than controls were observed. The significant differences were not observed between SCS patients 3 months after the procedure and controls' serum level of IFN-γ and other cytokines. We noticed a positive correlation between IFN-γ concentration with NRS back value before SCS and positive correlation between IFN-γ concentration after SCS with NRS leg value before SCS. Higher IFN-γ concentrations accompanied higher NRS values. Levels of TGF-β and IL-10 may correlate with physical ability and depressive behavior. CONCLUSIONS: SCS did not influence serum cytokine levels significantly. Serum concentration of IFN-γ may be recognized as an occasional pain factor because of its significantly higher level in FBSS patients versus controls and higher IFN-γ value accompanying higher pain intensity. |
format | Online Article Text |
id | pubmed-6348905 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Hindawi |
record_format | MEDLINE/PubMed |
spelling | pubmed-63489052019-02-12 The Elevated Serum Level of IFN-γ in Patients with Failed Back Surgery Syndrome Remains Unchanged after Spinal Cord Stimulation Kamieniak, Piotr Bielewicz, Joanna Grochowski, Cezary Litak, Jakub Bojarska-Junak, Agnieszka Daniluk, Beata Trojanowski, Tomasz Dis Markers Research Article OBJECTIVES: We investigated the influence of spinal cord stimulation (SCS) on IFN-γ, IL-1β, IL-6, TNF-α, IL-10, and TGF-β serum levels in failed back surgery syndrome (FBSS) patients. The study will try to give new insights into the mechanism of SCS action and the role of IFN-γ and other cytokines in neuropathic pain (NP) development. MATERIALS AND METHODS: Clinical and biochemical assessment was conducted in four groups of patients: group 0 consisted of 24 FBSS patients qualified to SCS therapy, group 1 included 17 patients who were one month after implantation, group 2 featured 12 patients who were 3 months after the implantation, and group C (the control group) with no NP. Clinical status was assessed with the use of Numeric Rating Scale (NRS), the Pain Rating Index of McGill Pain Questionnaire (SF-MPQ), the Oswestry Disability Index (ODI), and Beck Depression Inventory (BDI). The plasma concentrations of IFN-γ were ascertained by an immunoenzymatic method. RESULTS: We found a significant difference between the patients before SCS and controls' serum level of IFN-γ. Similarly, a significantly higher level of TNF-α and significantly lower level of IL-10 in FBSS patients than controls were observed. The significant differences were not observed between SCS patients 3 months after the procedure and controls' serum level of IFN-γ and other cytokines. We noticed a positive correlation between IFN-γ concentration with NRS back value before SCS and positive correlation between IFN-γ concentration after SCS with NRS leg value before SCS. Higher IFN-γ concentrations accompanied higher NRS values. Levels of TGF-β and IL-10 may correlate with physical ability and depressive behavior. CONCLUSIONS: SCS did not influence serum cytokine levels significantly. Serum concentration of IFN-γ may be recognized as an occasional pain factor because of its significantly higher level in FBSS patients versus controls and higher IFN-γ value accompanying higher pain intensity. Hindawi 2019-01-14 /pmc/articles/PMC6348905/ /pubmed/30755780 http://dx.doi.org/10.1155/2019/2606808 Text en Copyright © 2019 Piotr Kamieniak et al. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Kamieniak, Piotr Bielewicz, Joanna Grochowski, Cezary Litak, Jakub Bojarska-Junak, Agnieszka Daniluk, Beata Trojanowski, Tomasz The Elevated Serum Level of IFN-γ in Patients with Failed Back Surgery Syndrome Remains Unchanged after Spinal Cord Stimulation |
title | The Elevated Serum Level of IFN-γ in Patients with Failed Back Surgery Syndrome Remains Unchanged after Spinal Cord Stimulation |
title_full | The Elevated Serum Level of IFN-γ in Patients with Failed Back Surgery Syndrome Remains Unchanged after Spinal Cord Stimulation |
title_fullStr | The Elevated Serum Level of IFN-γ in Patients with Failed Back Surgery Syndrome Remains Unchanged after Spinal Cord Stimulation |
title_full_unstemmed | The Elevated Serum Level of IFN-γ in Patients with Failed Back Surgery Syndrome Remains Unchanged after Spinal Cord Stimulation |
title_short | The Elevated Serum Level of IFN-γ in Patients with Failed Back Surgery Syndrome Remains Unchanged after Spinal Cord Stimulation |
title_sort | elevated serum level of ifn-γ in patients with failed back surgery syndrome remains unchanged after spinal cord stimulation |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6348905/ https://www.ncbi.nlm.nih.gov/pubmed/30755780 http://dx.doi.org/10.1155/2019/2606808 |
work_keys_str_mv | AT kamieniakpiotr theelevatedserumlevelofifnginpatientswithfailedbacksurgerysyndromeremainsunchangedafterspinalcordstimulation AT bielewiczjoanna theelevatedserumlevelofifnginpatientswithfailedbacksurgerysyndromeremainsunchangedafterspinalcordstimulation AT grochowskicezary theelevatedserumlevelofifnginpatientswithfailedbacksurgerysyndromeremainsunchangedafterspinalcordstimulation AT litakjakub theelevatedserumlevelofifnginpatientswithfailedbacksurgerysyndromeremainsunchangedafterspinalcordstimulation AT bojarskajunakagnieszka theelevatedserumlevelofifnginpatientswithfailedbacksurgerysyndromeremainsunchangedafterspinalcordstimulation AT danilukbeata theelevatedserumlevelofifnginpatientswithfailedbacksurgerysyndromeremainsunchangedafterspinalcordstimulation AT trojanowskitomasz theelevatedserumlevelofifnginpatientswithfailedbacksurgerysyndromeremainsunchangedafterspinalcordstimulation AT kamieniakpiotr elevatedserumlevelofifnginpatientswithfailedbacksurgerysyndromeremainsunchangedafterspinalcordstimulation AT bielewiczjoanna elevatedserumlevelofifnginpatientswithfailedbacksurgerysyndromeremainsunchangedafterspinalcordstimulation AT grochowskicezary elevatedserumlevelofifnginpatientswithfailedbacksurgerysyndromeremainsunchangedafterspinalcordstimulation AT litakjakub elevatedserumlevelofifnginpatientswithfailedbacksurgerysyndromeremainsunchangedafterspinalcordstimulation AT bojarskajunakagnieszka elevatedserumlevelofifnginpatientswithfailedbacksurgerysyndromeremainsunchangedafterspinalcordstimulation AT danilukbeata elevatedserumlevelofifnginpatientswithfailedbacksurgerysyndromeremainsunchangedafterspinalcordstimulation AT trojanowskitomasz elevatedserumlevelofifnginpatientswithfailedbacksurgerysyndromeremainsunchangedafterspinalcordstimulation |